114 related articles for article (PubMed ID: 8869462)
1. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
Scandella D
Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
[TBL] [Abstract][Full Text] [Related]
2. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
[TBL] [Abstract][Full Text] [Related]
3. Mapping factor VIII inhibitor epitopes using hybrid human/porcine factor VIII molecules.
Lollar P
Haematologica; 2000 Oct; 85(10 Suppl):26-8; discussion 28-30. PubMed ID: 11187866
[TBL] [Abstract][Full Text] [Related]
4. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
5. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
[TBL] [Abstract][Full Text] [Related]
7. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
Yada K; Nogami K; Shima M
Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
[TBL] [Abstract][Full Text] [Related]
9. Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII.
Yada K; Nogami K; Ogiwara K; Shibata M; Shima M
Thromb Haemost; 2011 Jun; 105(6):989-98. PubMed ID: 21437361
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors in German hemophilia A patients treated with a double virus inactivated factor VIII concentrate bind to the C2 domain of FVIII light chain.
Laub R; Di Giambattista M; Fondu P; Brackmann HH; Lenk H; Saenko EL; Felch M; Scandella D
Thromb Haemost; 1999 Jan; 81(1):39-44. PubMed ID: 9974372
[TBL] [Abstract][Full Text] [Related]
11. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA
Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595
[TBL] [Abstract][Full Text] [Related]
12. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
[TBL] [Abstract][Full Text] [Related]
13. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
[TBL] [Abstract][Full Text] [Related]
14. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
Nogami K; Shima M; Nishiya K; Sakurai Y; Tanaka I; Giddings JC; Saenko EL; Yoshioka A
Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079
[TBL] [Abstract][Full Text] [Related]
15. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
[TBL] [Abstract][Full Text] [Related]
16. Analysis of factor VIII inhibitors using hybrid human/porcine factor VIII.
Lollar P
Thromb Haemost; 1997 Jul; 78(1):647-51. PubMed ID: 9198232
[TBL] [Abstract][Full Text] [Related]
17. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
Zhong D; Saenko EL; Shima M; Felch M; Scandella D
Blood; 1998 Jul; 92(1):136-42. PubMed ID: 9639509
[TBL] [Abstract][Full Text] [Related]
18. Properties of anti-factor VIII inhibitor antibodies in hemophilia A patients.
Scandella DH
Semin Thromb Hemost; 2000; 26(2):137-42. PubMed ID: 10919405
[TBL] [Abstract][Full Text] [Related]
19. Induction of human factor VIII inhibitors in rats 2: Fine mapping of rat anti-human rFVIII antibodies.
Levin LG; Jarvis M; Powell J; Harrison JA; Reisner HM
Thromb Haemost; 1996 Dec; 76(6):998-1003. PubMed ID: 8972024
[TBL] [Abstract][Full Text] [Related]
20. Dominant C2 domain epitope specificity of inhibitor antibodies elicited by a heat pasteurized product, factor VIII CPS-P, in previously treated hemophilia A patients without inhibitors.
Sawamoto Y; Prescott R; Zhong D; Saenko EL; Mauser-Bunschoten E; Peerlinck K; van den Berg M; Scandella D
Thromb Haemost; 1998 Jan; 79(1):62-8. PubMed ID: 9459325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
